Suppliers / Advanced Accelerator Applications

Advanced Accelerator Applications

France 590 employees Updated 9 July 2026

Advanced Accelerator Applications is a finished-dose manufacturer based in France. It appears in 5,122 regulatory filings across 32 regulators, without an active US DMF or CEP on file. Its filings concentrate with FAMHP (BE), INHRR (VE) and AIFA (IT). Its GMP standing is certified by ANSM (FR), EMA and ZLG (DE), among 8 authorities. Its most recent recorded inspection, by US FDA, closed on 27 June 2024 as VAI.

0
active US DMFs
0
valid CEPs
12
registered plants
5,122
filings across 32 regulators
These figures were checked against the regulators' own files on 25 July 2026
Inspections
0 of 4 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 27 June 2024 VAI US FDA
  • 3 November 2022 VAI US FDA
  • 9 November 2021 OAI US FDA
  • 18 August 2020 NAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Colleretto Giacosa, United Arab Emirates Not on file
North Rhine-Westphalia, Germany Not on file
Erlangen, Germany Not on file
Munich, Germany Not on file
Bonn, Germany Not on file
Hovedstaden, Denmark Not on file

6 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
FAMHP (BE) 1,005 None
INHRR (VE) 848 None
AIFA (IT) 821 None
EMA 414 13
URPL (PL) 252 None
INFARMED (PT) 242 None
ANSM (FR) None 41
ZLG (DE) None 12
AEMPS (ES) None 4
BPOM (ID) None 2
NAFDAC (NG) None 2
MFDS (Korea) None 2
US FDA None 1

Scale

Year Revenue Exports Destinations
2024 $55.5M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Advanced Accelerator Applications comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 27 June 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported